dobutamine

Generic: dobutamine

Labeler: slate run pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name dobutamine
Generic Name dobutamine
Labeler slate run pharmaceuticals
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

dobutamine hydrochloride 250 mg/20mL

Manufacturer
Slate Run Pharmaceuticals

Identifiers & Regulatory

Product NDC 70436-203
Product ID 70436-203_49562559-8e19-fb8a-e063-6394a90a0966
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA216131
Listing Expiration 2027-12-31
Marketing Start 2023-04-03

Pharmacologic Class

Classes
adrenergic beta-agonists [moa] beta-adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70436203
Hyphenated Format 70436-203

Supplemental Identifiers

RxCUI
1812168
UPC
0370436203802
UNII
0WR771DJXV

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name dobutamine (source: ndc)
Generic Name dobutamine (source: ndc)
Application Number ANDA216131 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 250 mg/20mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (70436-203-80) / 20 mL in 1 VIAL, SINGLE-DOSE
  • 10 VIAL, SINGLE-DOSE in 1 CARTON (70436-203-82) / 20 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (2)

Ingredients (1)

dobutamine hydrochloride (250 mg/20mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "49562559-8e19-fb8a-e063-6394a90a0966", "openfda": {"upc": ["0370436203802"], "unii": ["0WR771DJXV"], "rxcui": ["1812168"], "spl_set_id": ["ee09a55f-9992-48bb-b8d6-1184bd548536"], "manufacturer_name": ["Slate Run Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (70436-203-80)  / 20 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "70436-203-80", "marketing_start_date": "20230403"}, {"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (70436-203-82)  / 20 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "70436-203-82", "marketing_start_date": "20230403"}], "brand_name": "Dobutamine", "product_id": "70436-203_49562559-8e19-fb8a-e063-6394a90a0966", "dosage_form": "INJECTION", "pharm_class": ["Adrenergic beta-Agonists [MoA]", "beta-Adrenergic Agonist [EPC]"], "product_ndc": "70436-203", "generic_name": "dobutamine", "labeler_name": "Slate Run Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dobutamine", "active_ingredients": [{"name": "DOBUTAMINE HYDROCHLORIDE", "strength": "250 mg/20mL"}], "application_number": "ANDA216131", "marketing_category": "ANDA", "marketing_start_date": "20230403", "listing_expiration_date": "20271231"}